Description

Chumulin M3 (insulin) suspension for injections 100 IU/ml. 3 ml. cartridge №5

Ingredients:

Chumulin M3 contains insulin as the active ingredient. Other ingredients include suspending agents, preservatives, and pH adjusters.

Dosage:

Chumulin M3 is administered via subcutaneous injection. The dosage is individualized based on the patient’s needs and should be determined by a healthcare professional.

Indications:

Chumulin M3 is indicated for the treatment of diabetes mellitus to control high blood sugar. It helps regulate glucose levels in the body.

Contraindications:

Chumulin M3 is contraindicated in patients with hypersensitivity to insulin or any of the product components. It should not be used during episodes of hypoglycemia.

Directions:

Chumulin M3 should be injected under the skin, following the healthcare provider’s instructions. Rotate injection sites to prevent lipodystrophy.

Scientific Evidence:

Studies have shown the efficacy of Chumulin M3 in controlling blood glucose levels in patients with diabetes. Research published in the Journal of Clinical Endocrinology & Metabolism demonstrated the effectiveness of insulin suspensions like Chumulin M3 in improving glycemic control.

Additional Information:

It is important to monitor blood sugar levels regularly while using Chumulin M3 to adjust the dosage as needed. Consult a healthcare professional for proper usage and dosage adjustments.

Pharmacological Effects: Insulin works by promoting the uptake of glucose into cells, thereby reducing blood sugar levels. Chumulin M3, a suspension formulation, provides a prolonged effect, helping maintain stable glucose levels over an extended period.

Clinical Trials: Clinical trials comparing Chumulin M3 with other insulin formulations have shown similar efficacy in glycemic control. A study published in Diabetes Care compared the effects of different insulin suspensions, highlighting the comparable outcomes in blood sugar management.